CRISPR THERAPEUTICS
CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform. CRISPR/Cas9 is a revolutionary technology that allows for precise, directed changes to genomic DNA. They have licensed the foundational CRISPR/Cas9 patent estate for human therapeutic use from their scientific founder, Dr. Emmanuelle Charpentier, who co-invented the application of CRISPR/Cas9 for gene editing. CRISPR Therapeuticsโ vision is to cure serious human diseases at the molecular level using CRISPR-Cas9. The company is headquartered in Basel, Switzerland and has operations in London, UK.
CRISPR THERAPEUTICS
Industry:
Biopharma Biotechnology Genetics Medical
Founded:
2013-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.crisprtx.com
Total Employee:
101+
Status:
Active
Contact:
141794589327
Email Addresses:
[email protected]
Total Funding:
127 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Nginx Microsoft Exchange Online
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation investment in Grant - CRISPR Therapeutics
Wellington Capital Management
Wellington Capital Management investment in Series B - CRISPR Therapeutics
New Leaf Venture Partners
New Leaf Venture Partners investment in Series B - CRISPR Therapeutics
Clough Capital Partners
Clough Capital Partners investment in Series B - CRISPR Therapeutics
Franklin Templeton Investments
Franklin Templeton Investments investment in Series B - CRISPR Therapeutics
New Enterprise Associates
New Enterprise Associates investment in Series B - CRISPR Therapeutics
Versant Ventures
Versant Ventures investment in Series B - CRISPR Therapeutics
SR One
SR One investment in Series B - CRISPR Therapeutics
Abingworth
Abingworth investment in Series B - CRISPR Therapeutics
Vertex Pharmaceuticals
Vertex Pharmaceuticals investment in Series B - CRISPR Therapeutics
Key Employee Changes
Date | New article |
---|---|
2022-05-17 | On a Roll, CRISPR TX Taps Amgen Veteran P.K. Morrow as New CMO |
2021-10-14 | CRISPR Therapeutics Announces Transition of Chief Financial Officer |
Official Site Inspections
http://www.crisprtx.com Semrush global rank: 315.99 K Semrush visits lastest month: 197.21 K
- Host name: 64.62.152.250
- IP address: 64.62.152.250
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago